Page 139 - மருத்துவ+அவசர+ஊர்தி சேவை நம்பிக்கை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ+அவசர+ஊர்தி சேவை நம்பிக்கை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ+அவசர+ஊர்தி சேவை நம்பிக்கை Today - Breaking & Trending Today

Virtual presentation about Medicare set for June 8 for Central Coast seniors, caregivers

Virtual presentation about Medicare set for June 8 for Central Coast seniors, caregivers
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Ealth Insurance Counseling And Advocacy Program ,

What To Do When You Notice Your Aging Parents Are Starting To "Slip"

What To Do When You Notice Your Aging Parents Are Starting To "Slip"
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Durable Power , Aging Parents , Memory Loss , Normal Aging , Durable Power Of Attorney , Health Care , நீடித்த பவர் , நினைவு இழப்பு , நீடித்த பவர் ஆஃப் வழக்கறிஞர் , ஆரோக்கியம் பராமரிப்பு ,

Welcome To IANS Live - BUSINESS - Samsung, Sony, Hitachi invest in UK healthtech firm Huma


Photo Credit: IANS
IANSLive
London, May 12 (IANS) Samsung, Sony and Hitachi have invested in UK heathtech company Huma Therapeutics Limited in its latest Series C funding round with financing of approximately $130 million, the company said on Wednesday.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 12-May-2021 ....

United Kingdom , City Of , Huma Therapeutics , News Service , India Private , Huma Therapeutics Limited , All Rights , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஹுமா சிகிச்சை , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 [...]


12 maggio 2021 16:52
Fonte: Adnkronos
#salute-e-benessere
Product recently cleared in EU as Class III medical device
BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Resul ....

United States , Switzerland General , Paolo Galfetti , Professorgiancarlo Icardi , Giancarlo Icardi , Pharma Research , Hygiene Unit , San Martino Hospital , Antiviral Research , Utah State University , Apr Aos2020 , ஒன்றுபட்டது மாநிலங்களில் , சுவிட்சர்லாந்து ஜநரல் , பார்மா ஆராய்ச்சி , சுகாதாரம் அலகு , சான் மார்டினோ மருத்துவமனை , உட்டா நிலை பல்கலைக்கழகம் ,